Next Article in Journal
Essential Oils from Monarda fistulosa: Chemical Composition and Activation of Transient Receptor Potential A1 (TRPA1) Channels
Next Article in Special Issue
The Cholinesterase Inhibitory Properties of Stephaniae Tetrandrae Radix
Previous Article in Journal
MH-ICP-MS Analysis of the Freshwater and Saltwater Environmental Resources of Upolu Island, Samoa
Previous Article in Special Issue
Solvent Deuterium Oxide Isotope Effects on the Reactions of Organophosphorylated Acetylcholinesterase
Open AccessFeature PaperArticle

Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors

1
Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, 10000 Zagreb, Croatia
2
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev trg 19, 10000 Zagreb, Croatia
3
Division of Physical Chemistry, Rudjer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Derek J. McPhee
Molecules 2020, 25(21), 4872; https://doi.org/10.3390/molecules25214872
Received: 6 October 2020 / Revised: 19 October 2020 / Accepted: 20 October 2020 / Published: 22 October 2020
(This article belongs to the Special Issue Enzymes Reacting with Organophosphorus Compounds)
A library of amine, oxime, ether, epoxy and acyl derivatives of the benzobicyclo[3.2.1]octene were synthesized and evaluated as inhibitors of both human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The majority of the tested compounds exhibited higher selectivity for BChE. Structural adjustment for AChE seems to have been achieved by acylation, and the furan ring opening of furo-benzobicyclo[3.2.1]octadiene results for compound 51 with the highest AChE affinity (IC50 = 8.3 µM). Interestingly, its analogue, an oxime ether with a benzobicyclo[3.2.1]-skeleton, compound 32 was one of the most potent BChE inhibitors in this study (IC50 = 31 µM), but not as potent as endo-43, an ether derivative of the benzobicyclo[3.2.1]octene with an additional phenyl substituent (IC50 = 17 µM). Therefore, we identified several cholinesterase inhibitors with a potential for further development as potential drugs for the treatment of neurodegenerative diseases. View Full-Text
Keywords: acylation; benzobicyclo[3.2.1]octane/octene; benzylamines; cholinesterase; epoxidation; oximes acylation; benzobicyclo[3.2.1]octane/octene; benzylamines; cholinesterase; epoxidation; oximes
Show Figures

Graphical abstract

MDPI and ACS Style

Čadež, T.; Grgičević, A.; Ahmetović, R.; Barić, D.; Hrvat, N.M.; Kovarik, Z.; Škorić, I. Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors. Molecules 2020, 25, 4872. https://doi.org/10.3390/molecules25214872

AMA Style

Čadež T, Grgičević A, Ahmetović R, Barić D, Hrvat NM, Kovarik Z, Škorić I. Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors. Molecules. 2020; 25(21):4872. https://doi.org/10.3390/molecules25214872

Chicago/Turabian Style

Čadež, Tena; Grgičević, Ana; Ahmetović, Ramiza; Barić, Danijela; Hrvat, Nikolina M.; Kovarik, Zrinka; Škorić, Irena. 2020. "Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors" Molecules 25, no. 21: 4872. https://doi.org/10.3390/molecules25214872

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop